Abstract:Background: It is universally accepted that change of specific proteins is of great significance in the development of tumor and post translational modification (PTM) is a major way to modify protein activity. O-GlcNAcylation,as one of post translational modifications of proteins regulated by OGT and OGA, has linked glucose metabolism disorders with the malignancies. Numerous studies have demonstrated the aberrant activation of O-GlcNAcylation and OGT in tumors. The aim of this study is to investigate the potential role and underlying mechanisms of O-GlcNAcylation in HCC progression.Methods: The level of O-GlcNAcylation was detected by IHC staining and western blot. Function of O-GlcNAcylationin HCC proliferation was investigated by CCK8, BrdU, colony forming, cell cycle assay and subcutaneous xenograft tumor model. Scratch healing, transwell assay and 3D spheroid invasion assay were employed for testing metastatic ability of cells. Moreover, Mass-spectrum and co-IP assay were performed to explore novel OGT binding proteins.Results: Total O-GlcNAcylation level of proteins was markedly overexpressed in HCC compared to adjacent normal tissues and the upregulation of O-GlcNAcylation was associated with poor outcome of patients. The results of in vitro and vivoexperiments showed consistently that high level of O-GlcNAcylation could promote HCC proliferation and metastasis. A large number of studies show that the O-GlcNAcylation of key protein is the crucial step for O-GlcNAcylation regulation in tumor. We examined the mass spectrum results of HCC cell line IP-OGT samples and found 214 eligible candidates. Then GO annotation and the KEGG pathway analysis was employed to try to find targets within the tumor related range. Among the potential candidates which could related to tumor transcription misregulation, we find out that SIX1 which could regulate a series of downstream oncogenic factors and glycolysis related genes including c-myc, cyclin D1, GLUT1 and ENO1 to be a possible effect factor of O-GlcNAcylation. The further data demonstrated that SIX1 was modified by O-GlcNAcylation, and O-GlcNAcylation could maintain the high expression status of SIX1 by inhibiting itsubiquitination degradation.Conclusions: In conclusion, our data suggest that O-GlcNAcylation significantly increased in HCC compared to normal tissues. The high expression of O-GlcNAcylation could be an independent prognostic factor in HCC and was associated with poor outcome of patients. Further, we find out SIX1 was the underlying executor of O-GlcNAcylation in HCC. By inhibiting SIX1 ubiquitination, O-GlcNAcylation could maintain SIX1 and its downstream factors in a high level persistently and therefore promote HCC progression. Here in our study, we for the first time identified a neo-posttranslation O-GlcNAcytion modification pathway in HCC, which could provide potential therapy for HCC treatment.Citation Format: Yongzhan Nie, Yi Chu, Daiming Fan, Mingzuo Jiang, Nan Wu, Hongwei Li. Hyper O-GlcNAcylation plays an oncogenic role in hepatocellular cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 848.

Upregulation of OGT by Caveolin‐1 promotes hepatocellular carcinoma cell migration and invasion

O‐GlcNAcylation Promotes the Migratory Ability of Hepatocellular Carcinoma Cells Via Regulating FOXA2 Stability and Transcriptional Activity

Chromatin-associated OGT promotes the malignant progression of hepatocellular carcinoma by activating ZNF263

Caveolin‐1 upregulates Fut8 expression by activating the Wnt/β‐catenin pathway to enhance HCC cell proliferative and invasive ability

C1GALT1-mediated O-glycan T antigen increase enhances the migration and invasion ability of gastric cancer cells

OGT/HIF-2α Axis Promotes the Progression of Clear Cell Renal Cell Carcinoma and Regulates Its Sensitivity to Ferroptosis

O‐GlcNAc transferase activates stem‐like cell potential in hepatocarcinoma through O‐GlcNAcylation of eukaryotic initiation factor 4E

Orosomucoid 2 Inhibits Tumor Metastasis and is Upregulated by CCAAT/enhancer Binding Protein Β in Hepatocellular Carcinomas

Proteomic Analysis of the OGT Interactome: Novel Links to Epithelial-Mesenchymal Transition and Metastasis of Cervical Cancer

Caveolin-1 up-regulates CD147 glycosylation and the invasive capability of murine hepatocarcinoma cell lines.

Caveolin-1 promotes invasion and metastasis by upregulating Pofut1 expression in mouse hepatocellular carcinoma

Caveolin-1 facilitates cell migration by upregulating nuclear receptor 4A2/retinoid X receptor α-mediated β-galactoside α2,6-sialyltransferase I expression in human hepatocarcinoma cells

O-GlcNAcylation Plays a Role in Tumor Recurrence of Hepatocellular Carcinoma Following Liver Transplantation.

Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB

Caveolin-1 Is Up-Regulated By Gli1 And Contributes To Gli1-Driven Emt In Hepatocellular Carcinoma

CAV1 Promotes HCC Cell Progression and Metastasis Through Wnt/β-catenin Pathway.

Abstract 848: Hyper O-GlcNAcylation Plays an Oncogenic Role in Hepatocellular Cancer

O-GlcNAcylation Mediates Metastasis of Cholangiocarcinoma Through FOXO3 and MAN1A1

Caveolin-1 promotes Rfng expression via Erk-Jnk-p38 signaling pathway in mouse hepatocarcinoma cells

Regulation and Clinical Significance of O-GlcNAc Transferase in Cancer

The crosstalk network of XIST/miR‐424‐5p/OGT mediates RAF1 glycosylation and participates in the progression of liver cancer